Advanced ras-mutated colorectal cancer with liver metastases (CRLM)

Clinical trials for Advanced ras-mutated colorectal cancer with liver metastases (CRLM) explained in plain language.

Never miss a new study

Get alerted when new Advanced ras-mutated colorectal cancer with liver metastases (CRLM) trials appear

Sign up with your email to follow new studies for Advanced ras-mutated colorectal cancer with liver metastases (CRLM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a new drug combo shrink liver tumors in Hard-to-Treat colorectal cancer?

Disease control Not yet recruiting

This phase II trial tests whether adding retlirafusp alfa to standard chemotherapy and bevacizumab can shrink tumors in people with advanced RAS-mutated colorectal cancer that has spread to the liver. The study enrolls 46 adults who have not had prior systemic treatment and whose…

Matched conditions: ADVANCED RAS-MUTATED COLORECTAL CANCER WITH LIVER METASTASES (CRLM)

Phase 2 • Sponsor: Dai, Guanghai • Aim: Disease control

Last updated Sep 03, 2026 00:00 UTC

Advanced ras-mutated colorectal cancer with liver metastases (CRLM)

Get alerted when new Advanced ras-mutated colorectal cancer with liver metastases (CRLM) trials appear

Can a new drug combo shrink liver tumors in Hard-to-Treat colorectal cancer?